Literature DB >> 3023202

Unusual occurrence of EcoP1 and EcoP15 recognition sites and counterselection of type II methylation and restriction sequences in bacteriophage T7 DNA.

C Schroeder, H Jurkschat, A Meisel, J G Reich, D Krüger.   

Abstract

Selected and counterselected oligodeoxynucleotide sequences were identified in the total sequence of bacteriophage T7 DNA using a statistical criterion derived for a probability model of the Markov chain type. All extremely rare tetra- and pentadeoxynucleotides are (or contain) recognition sequences for the Escherichia coli DNA methylases dam or dcm. Most of the 37 hexadeoxynucleotides absent from T7 DNA are recognition sequences for type II modification/restriction enzymes of E. coli or related species. In contrast to most restriction sites counterselected during evolution, the EcoP1 site GGTCT occurs 126 times in the T7 genome, and phage T7 replication is severely repressed in P1-lysogenic host cells. We demonstrate that the frequency of the EcoP1 site is determined by that of the overlapping recognition sites for T7 primase, an essential phage enzyme. The recognition site of a type III enzyme, EcoP15, is also not counterselected. In T7 DNA all 36 EcoP15 sites are arranged in such a manner that the sequence CAGCAG is confined to the H strand, the complementary sequence CTGCTG to the L strand. This "strand bias" is highly significant and, therefore, very probably selected. A functional relation between this strand bias and the refractive behaviour of phage T7 to EcoP15 restriction is suspected.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3023202     DOI: 10.1016/0378-1119(86)90134-4

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  11 in total

1.  Inhibition of gene expression of T7-related phages by prophage P1.

Authors:  R Hausmann; M Messerschmid
Journal:  Mol Gen Genet       Date:  1988-06

Review 2.  Diverse functions of restriction-modification systems in addition to cellular defense.

Authors:  Kommireddy Vasu; Valakunja Nagaraja
Journal:  Microbiol Mol Biol Rev       Date:  2013-03       Impact factor: 11.056

Review 3.  Avoidance of DNA methylation. A virus-encoded methylase inhibitor and evidence for counterselection of methylase recognition sites in viral genomes.

Authors:  D H Krüger; C Schroeder; M Santibanez-Koref; M Reuter
Journal:  Cell Biophys       Date:  1989 Aug-Oct

4.  EcoRII can be activated to cleave refractory DNA recognition sites.

Authors:  D H Krüger; G J Barcak; M Reuter; H O Smith
Journal:  Nucleic Acids Res       Date:  1988-05-11       Impact factor: 16.971

Review 5.  Biology of DNA restriction.

Authors:  T A Bickle; D H Krüger
Journal:  Microbiol Rev       Date:  1993-06

6.  Halophage HF2: genome organization and replication strategy.

Authors:  S D Nuttall; M L Dyall-Smith
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

7.  Characterization of a T7-like lytic bacteriophage (phiSG-JL2) of Salmonella enterica serovar gallinarum biovar gallinarum.

Authors:  Hyuk-Joon Kwon; Sun-Hee Cho; Tae-Eun Kim; Yong-Jin Won; Jihye Jeong; Se Chang Park; Jae-Hong Kim; Han-Sang Yoo; Yong-Ho Park; Sun-Joong Kim
Journal:  Appl Environ Microbiol       Date:  2008-09-26       Impact factor: 4.792

8.  Dissociation from DNA of Type III Restriction-Modification enzymes during helicase-dependent motion and following endonuclease activity.

Authors:  Júlia Tóth; Kara van Aelst; Hannah Salmons; Mark D Szczelkun
Journal:  Nucleic Acids Res       Date:  2012-04-20       Impact factor: 16.971

9.  Type III restriction endonucleases translocate DNA in a reaction driven by recognition site-specific ATP hydrolysis.

Authors:  A Meisel; P Mackeldanz; T A Bickle; D H Krüger; C Schroeder
Journal:  EMBO J       Date:  1995-06-15       Impact factor: 11.598

10.  Characterization of the Type III restriction endonuclease PstII from Providencia stuartii.

Authors:  Alice Sears; Luke J Peakman; Geoffrey G Wilson; Mark D Szczelkun
Journal:  Nucleic Acids Res       Date:  2005-08-24       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.